Hoppa till huvudinnehåll

SIL1 nucleotide exchange factor

Den SIL1 gene provides instructions for producing a protein located in a cell structure called the endoplasmic reticulum. Among its many functions, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape. The SIL1 protein works with BiP, a protein that helps fold newly produced proteins into the proper shape and refold damaged proteins. To start this process, BiP attaches (binds) to a molecule called adenosine triphosphate (ATP). When BiP folds a protein, the ATP is converted to a similar molecule called adenosine diphosphate (ADP). Then the SIL1 protein releases ADP from BiP so that it can bind to another molecule of ATP and start the protein folding process again. Because of its role in helping BiP exchange ADP for ATP, the SIL1 protein is called a nucleotide exchange factor.

Videoval för Genes
Videobibliotek

Normal function

Den SIL1 gene provides instructions for producing a protein located in a cell structure called the endoplasmic reticulum. Among its many functions, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape. The SIL1 protein works with BiP, a protein that helps fold newly produced proteins into the proper shape and refold damaged proteins. To start this process, BiP attaches (binds) to a molecule called adenosine triphosphate (ATP). When BiP folds a protein, the ATP is converted to a similar molecule called adenosine diphosphate (ADP). Then the SIL1 protein releases ADP from BiP so that it can bind to another molecule of ATP and start the protein folding process again. Because of its role in helping BiP exchange ADP for ATP, the SIL1 protein is called a nucleotide exchange factor.

Conditions referring to this gene or chromosome

Other names

BAP

BiP-associated protein

MSS

SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae)

SIL1 protein

SIL1_HUMAN

ULG5

Related patient information and medicines

Halscancer

Patient information leaflet

Halscancer

(The throat is usually sprayed with a local anaesthetic before use of a nasal endoscope, so that the procedure i... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their.

Muncancer

Patient information leaflet

Muncancer

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Orsaker till cancer

Patient information leaflet

Orsaker till cancer

Certain risk factors are known to increase the chance that one or more of your cells will become abnormal and lead to cancer. How does cancer start. Different parts of the body such as organs, bones... Most cells have a centre called a nucleus. The nucleus in each cell contains thousands of genes which are made up from a chemical called DNA. The.

Akut lymfatisk leukemi

Patient information leaflet

Akut lymfatisk leukemi

Cell- och kromosomanalys Detailed tests are done on. These find out the exact type of cell that is abnormal - for example, if the abnormal cells are immature B lymphocytes or immature T lymphocytes. The chromosomes within the cells are checked for certain changes. Chromosomes are the parts in the cell which contain DNA - the genetic makeup of.

Myelom

Patient information leaflet

Myelom

See Further Reading and References below. Dr Krishna Vakharia, 27th June 2023 Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma NICE has recommended the above treatment regime for those people who have had one treatment already with lenalidomide or if the lenalidomide cannot be used again as a second line.

Retinal ventrombos

Patient information leaflet

Retinal ventrombos

Villkor which increase the risk of retinal vein occlusion include. High cholesterol/high lipid levels. Raised pressure in the eye (glaucoma). Diabetes. Smoking. Conditions which 'thicken' the blood. What are the symptoms of retinal vein occlusion. If you have retinal vein occlusion, you will usually notice a decrease in your vision in one eye..

Vidare läsning och referenser

Artikelhistorik

Informationen på denna sida är skriven och granskad av kvalificerade kliniker.
  • 18 aug 2020 | Senaste versionen
  • 1 Sept 2008 | Ursprungligen publicerad

Delta i konversationen

Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.

Ansvarsfriskrivning: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Onlineapotek, behandlingar och hälsotjänster

Enkel tillgång till pålitliga behandlingar och hälsotjänster online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Anmäl dig till Patientens nyhetsbrev

Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.

Vänligen ange en giltig e-postadress

Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.